Split First Dose Administration of Intravenous Daratumumab for the Treatment of Multiple Myeloma (MM): Clinical and Population Pharmacokinetic Analyses
Advances in Therapy- United States
doi 10.1007/s12325-020-01247-8
Full Text
Abstract
Available in
Date
February 20, 2020
Authors
Publisher
Springer Science and Business Media LLC